APOE genotype and brain amyloid are associated with changes in the plasma proteome in elderly subjects without dementia
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.52250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Sarah M Philippi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nash Family Department of Neuroscience, Department of Neurology, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New Yor…. Hauptthemen laut MEDLINE: Proteome, Brain, Apolipoprotein E4, Apolipoproteins E. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Adult Children Study, NIMH NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Objective
Recent work has bolstered the possibility that peripheral changes may be relevant to Alzheimer's disease pathogenesis in the brain. While age‐associated blood‐borne proteins have been targeted to restore function to the aged brain, it remains unclear whether other dysfunctional systemic states can be exploited for similar benefits. Here, we investigate whether APOE allelic variation or presence of brain amyloid are associated with plasma proteomic changes and the molecular processes associated with these changes.
Methods
Using the SOMAscan assay, we measured 1305 plasma proteins from 53 homozygous, APOE3 and APOE4 subjects without dementia. We investigated the relationship of either the APOE‐ε4 allele or amyloid positivity with plasma proteome changes by linear mixed effects modeling and ontology‐based pathway and module–trait correlation analyses.
Results
APOE4 is associated with plasma protein differences linked to atherosclerosis, tyrosine kinase activity, cholesterol transport, extracellular matrix, and synaptogenesis pathways. Independent of APOE4 , we found that subjects likely harboring brain amyloid exhibit plasma proteome signatures associated with AD‐linked pathways, including neurovascular dysfunction.
Interpretation
Our results indicate that APOE4 status or presence of brain amyloid are associated with plasma proteomic shifts prior to the onset of symptoms, suggesting that systemic pathways in certain risk contexts may be plausible targets for disease modification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nash Family Department of Neuroscience, Department of Neurology, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Ronald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Joseph M Castellano
Förderung
- NIA NIH HHS
- Adult Children Study
- NIMH NIH HHS
- BrightFocus Foundation
- 2015 New Vision Research Investigator Award, Charleston Conference on AD
- Charles F. and Joanne Knight Alzheimer Disease Research Center
- National Institute of Mental Health
- National Institute on Aging
Zitieren
APA
Philippi, S. M., Bp, K., Raj, T., & Castellano, J. M. (2025). APOE genotype and brain amyloid are associated with changes in the plasma proteome in elderly subjects without dementia. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52250
Vancouver
Philippi SM, Bp K, Raj T, Castellano JM. APOE genotype and brain amyloid are associated with changes in the plasma proteome in elderly subjects without dementia. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.52250
BibTeX
@article{Philippi2025,
author = {Philippi, Sarah M and Bp, Kailash and Raj, Towfique and Castellano, Joseph M},
title = {APOE genotype and brain amyloid are associated with changes in the plasma proteome in elderly subjects without dementia},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.52250}
}
EUVIMED